-

MedsEngine Selected as Finalist in Payor Category of the Emerge Innovation Contest at HIMSS25

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine, a clinical decision support software designed to optimize treatment for hypertension, cholesterol, type 2 diabetes, and heart failure, is proud to announce they were selected as a finalist in the payor category of the Emerge Innovation Experience Contest at HIMSS25.

Dr. Doug Romer, MedsEngine CMO, stated, “given the level of competition, having MedsEngine recognized among innovative solutions that are transforming healthcare delivery is truly an honor and recognition of the value that MedsEngine provides in improving patient outcomes and reducing the overall cost of care.”

Users of the MedsEngine hypertension module have reported outstanding results, with more than 90% of their patients achieving a blood pressure of <140/90 in less than two visits for ten consecutive years. Romer added, “these results are industry leading and show the benefits of utilizing technology. Guideline recommendations work if they are used, unfortunately, complexity and time limitations often limit their use. MedsEngine empowers providers to apply guideline treatment recommendations for hypertension, cholesterol and type 2 diabetes in seconds.”

MedsEngine will be exhibiting its innovative platform at HIMSS25. Visit booth 2567 to see a live demonstration and learn how MedsEngine is transforming chronic disease control.

To learn more about MedsEngine visit www.medsengine.com.

Contacts

mike.gearhardt@medsengine.com

Industry:

MedsEngine

Release Versions
English

Contacts

mike.gearhardt@medsengine.com

More News From MedsEngine

MedsEngine Achieves SOC 2 Type II Certification: Reinforcing Our Commitment to Data Security

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine, a provider of chronic disease management software, is proud to announce that it has successfully attained SOC 2 Type II certification. This certification, awarded by the American Institute of Certified Public Accountants (AICPA), is a rigorous audit that evaluates a company's controls relevant to security, availability, processing integrity, confidentiality, and privacy. Dr. Doug Romer, CMO, stated, “this milestone underscores MedsEngine’s continued co...

MedsEngine Announces Integration with AthenaOne EHR at Volunteers in Medicine

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine LLC is excited to announce its clinical decision support application is now integrated with AthenaOne EHR at the Volunteers in Medicine (VIM) Clinic in Hilton Head, SC. Dr. John Newman of VIM states, “partnering with MedsEngine allows our volunteer physicians, who come from a wide spectrum of medical backgrounds, to have greater confidence in their abilities to control chronic diseases in a primary care setting.” “Integrating our application with Athena...

MedsEngine Presents at ESC in London, U.K.

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine LLC is a clinical decision support company that develops software for treating chronic disease. Data was presented on cerebrovascular events and myocardial infarctions in patients treated with MedsEngine-Hypertension at the 2024 European Society of Cardiology Congress in London, U.K. Hypertension is recognized as a leading cause of atherosclerotic cardiovascular disease and death globally. Data was retrieved from EHRs for a period of seven years for pat...
Back to Newsroom